Premium
The regulation of the UK pharmaceutical industry: A cost‐benefit analysis
Author(s) -
Hartley Keith,
Maynard Alan
Publication year - 1982
Publication title -
managerial and decision economics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 51
eISSN - 1099-1468
pISSN - 0143-6570
DOI - 10.1002/mde.4090030304
Subject(s) - pharmaceutical industry , product (mathematics) , industrial organization , business , economics , public economics , microbiology and biotechnology , geometry , mathematics , biology
Regulation is not costless. It can have adverse effects on innovation, on the time required to develop a new product and on an industry's competitiveness. This article estimates the costs of regulating the UK pharmaceutical industry and whether the results are worthwhile.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom